These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37269641)

  • 1. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection.
    Samara A; Cantoni C; Piccio L; Cross AH; Chahin S
    Mult Scler Relat Disord; 2023 Aug; 76():104768. PubMed ID: 37269641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis.
    Shahi SK; Ghimire S; Lehman P; Mangalam AK
    Front Immunol; 2022; 13():966417. PubMed ID: 36164343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
    Solas M; Milagro FI; Ramírez MJ; Martínez JA
    Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation.
    Rebeaud J; Peter B; Pot C
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives.
    Altieri C; Speranza B; Corbo MR; Sinigaglia M; Bevilacqua A
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
    Kumar N; Sahoo NK; Mehan S; Verma B
    Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
    Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
    J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
    Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
    Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
    Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?
    Musso G; Gambino R; Cassader M
    Diabetes Care; 2010 Oct; 33(10):2277-84. PubMed ID: 20876708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
    Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
    Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and obesity: The role of adipokines.
    Correale J; Marrodan M
    Front Immunol; 2022; 13():1038393. PubMed ID: 36457996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet.
    Díez-Sainz E; Milagro FI; Riezu-Boj JI; Lorente-Cebrián S
    J Physiol Biochem; 2022 May; 78(2):485-499. PubMed ID: 34472032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Fan Y; Zhang J
    Front Microbiol; 2019; 10():740. PubMed ID: 31040833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.
    van den Hoogen WJ; Laman JD; 't Hart BA
    Front Immunol; 2017; 8():1081. PubMed ID: 28928747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    J Obes; 2016; 2016():7353642. PubMed ID: 27703805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the gut microbiota and microbial metabolites in neuroinflammation.
    Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
    Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.